Recent CDC issuances of Level 2 Travel Health Notices—including meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio circulation across over 30 countries (March 9)—have propelled the 75% market-implied odds for a Level 3 "Reconsider Nonessential Travel" notice by December 31. These alerts signal escalating outbreaks in vaccine-preventable and mosquito-borne pathogens, with confirmed cases and sustained transmission prompting enhanced precautions. Trader consensus, backed by real capital, reflects epidemiological trends where Level 2 designations frequently upgrade amid surging case counts or geographic spread, as seen historically with polio and mpox clade II. Uncertainties persist in disease trajectories, but upcoming surveillance reports from CDC could tip outcomes; monitor polio, yellow fever, and potential H5N1 developments.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$112,110 ปริมาณ
$112,110 ปริมาณ
Dec 31, 2026
$112,110 ปริมาณ
$112,110 ปริมาณ
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Recent CDC issuances of Level 2 Travel Health Notices—including meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio circulation across over 30 countries (March 9)—have propelled the 75% market-implied odds for a Level 3 "Reconsider Nonessential Travel" notice by December 31. These alerts signal escalating outbreaks in vaccine-preventable and mosquito-borne pathogens, with confirmed cases and sustained transmission prompting enhanced precautions. Trader consensus, backed by real capital, reflects epidemiological trends where Level 2 designations frequently upgrade amid surging case counts or geographic spread, as seen historically with polio and mpox clade II. Uncertainties persist in disease trajectories, but upcoming surveillance reports from CDC could tip outcomes; monitor polio, yellow fever, and potential H5N1 developments.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Jan 19, 2026, 3:15 PM ET
ปริมาณการซื้อขาย
$112,110วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Recent CDC issuances of Level 2 Travel Health Notices—including meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio circulation across over 30 countries (March 9)—have propelled the 75% market-implied odds for a Level 3 "Reconsider Nonessential Travel" notice by December 31. These alerts signal escalating outbreaks in vaccine-preventable and mosquito-borne pathogens, with confirmed cases and sustained transmission prompting enhanced precautions. Trader consensus, backed by real capital, reflects epidemiological trends where Level 2 designations frequently upgrade amid surging case counts or geographic spread, as seen historically with polio and mpox clade II. Uncertainties persist in disease trajectories, but upcoming surveillance reports from CDC could tip outcomes; monitor polio, yellow fever, and potential H5N1 developments.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$112,110วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Recent CDC issuances of Level 2 Travel Health Notices—including meningococcal disease in the Democratic Republic of the Congo (March 24, 2026), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio circulation across over 30 countries (March 9)—have propelled the 75% market-implied odds for a Level 3 "Reconsider Nonessential Travel" notice by December 31. These alerts signal escalating outbreaks in vaccine-preventable and mosquito-borne pathogens, with confirmed cases and sustained transmission prompting enhanced precautions. Trader consensus, backed by real capital, reflects epidemiological trends where Level 2 designations frequently upgrade amid surging case counts or geographic spread, as seen historically with polio and mpox clade II. Uncertainties persist in disease trajectories, but upcoming surveillance reports from CDC could tip outcomes; monitor polio, yellow fever, and potential H5N1 developments.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย